Pilot study of the FoxP3+ T lymphocyte count and its relationship with the Gensini score in patients with coronary heart disease and type 2 diabetes mellitus from a South American cohort
Epidemiology
FOXP3
Immunological Mechanisms in Atherosclerosis Development
Immunology
Cardiology
Coronary artery disease
Diabetes mellitus
Endocrinology
Biochemistry, Genetics and Molecular Biology
Health Sciences
Genetics
Internal medicine
Genetics and Pathogenesis of Type 1 Diabetes
Immunology and Microbiology
FOS: Clinical medicine
Life Sciences
T cell
Type 2 diabetes
IL-2 receptor
Type 2 Diabetes
Inflammation and Obesity-Related Metabolic Disorders
Type 2 Diabetes Mellitus
Immune system
FOS: Biological sciences
Type 1 Diabetes
Medicine
DOI:
10.1101/2023.10.08.23296720
Publication Date:
2023-10-09T19:15:26Z
AUTHORS (11)
ABSTRACT
AbstractINTRODUCTIONOne of the pathogenic links between type 2 diabetes mellitus (T2DM) and coronary heart disease (CHD) is low-intensity chronic inflammation, which is limited by FoxP3+ regulatory T cells.MATERIALS AND METHODSA comparative, observational, single-center, single-stage study was carried out. The severity of atherosclerosis was assessed by calculating the Gensini score based on selective coronary angiography. The absolute and relative content of CD4+CD25 high FoxP3+ and CD4+CD25 low FoxP3+ T cells in the blood was evaluated by flow cytometry.RESULTS57 patients with chronic ischemic heart disease were examined. Patients with a combination of CHF and T2DM are characterized by an increase in the relative and absolute content of FoxP3+CD25 lymphocytes in the peripheral blood and an increase in the intranuclear content of FoxP3 in them, which is more pronounced in patients with disease moderate. atherosclerosis (Gensini score 17 to 45 points).CONCLUSIONSThis was the first Latin American study that managed to show the relationship between an increase in the content of low FoxP3+CD25 lymphocytes in the peripheral blood with atherosclerosis in patients with a combination of coronary artery disease and DM2.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (17)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....